http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2018351515-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77a9cc032e10e878d42bfe8c198ffc3b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F17-00 |
| filingDate | 2018-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f11f6a3a3e8fa1cb55674eb4017bb6d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_decca5c0a600852e927d654c10879225 |
| publicationDate | 2020-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2018351515-A1 |
| titleOfInvention | Methods and systems for enhancing safety of psychedelic drug therapies |
| abstract | The present invention provides methods and systems of enhancing the safety of psychedelic drug therapies (e.g., 5-HT2A agonists (e.g., LSD and psilocybin), dissociatives, and empathogens), for example, as part of a complex therapy. In particular, the invention features methods and systems for reducing the risk of developing psychosis, hypomania, or mania associated with psychedelic therapy. |
| priorityDate | 2017-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 221.